Tetrandrine Tablets Used in the Treatment of COVID-19

Summary

The study is expected to treat patients with mild and severe neo-coronary pneumonia through standard treatment regimens in combination with tetrandrine tablets, thereby reducing the clinical progress of some patients, improving prognosis, reducing the incidence of pulmonary fibrosis during rehabilitation, and improving patients' quality of life.

Timeline

Start

2020-03-05

Primary completion

2021-03-01

Completion

2021-05-01

Drugs

Indications